MedPath

the effect of vitamin D in the treatment of chemotherapy-induced fever and neutropenia in children with malignancy

Phase 3
Conditions
Fever and neutropenia.
Registration Number
IRCT20240608062045N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

pediatric hematology and oncology department of Amirkabir Arak Hospital, aged 1 to 16 years, with fever and neutropenia due to chemotherapy, informed consent of the patient's parents for the child to participate in the study, the initial vitamin D level is lower than the normal level) by the initial vitamin D level test D is measured and values ??less than 20 ng/ml are considered as deficiency and values ??of 29 ng/ml are considered as insufficient.) Not taking vitamins arbitrarily

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fever and neutropenia. Timepoint: For each patient on the 3rd, 7th, 10th, 14th day, the results are recorded as full treatment, partial treatment or no treatment. Method of measurement: The level of neutropenia is checked by the CBC test, which is routinely taken every other day from hospitalized patients, and The degree of fever is also recorded by the ward nurse with a thermometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath